OPTION: A Trial to Assess the Safety & Efficacy of MS1819 in Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis

Clinical trial NCT03746483 · COMPLETED

Trial details

NCT number: NCT03746483
Sponsor: Entero Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Exocrine Pancreatic Insufficiency (EPI)Cystic Fibrosis (CF)

Start date: 2019-01-10
Primary completion: 2019-07-13
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.